Evidence map›Paper›PMID 36229725›Full record

ArticleVeterinary research communications2023

A cross-sectional serosurvey of SARS-CoV-2 and co-infections in stray cats from the second wave to the sixth wave of COVID-19 outbreaks in Spain.

Sergio Villanueva-Saz, Mariví Martínez, Jacobo Giner, Ana González, Ana Pilar Tobajas, María Dolores Pérez, Erandi Lira-Navarrete, Andrés Manuel González-Ramírez, Javier Macías-León, Maite Verde and 9 more

Open access · bronzeAbstract read
In one paragraph

Article in Veterinary research communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Exposure of Wild Ruminants toVeterinary sciences · 2025
    Article
  5. Review
  6. Serum protein electrophoresis in European mink (The veterinary quarterly · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Prevalence ofAnimals : an open access journal from MDPI · 2023
    Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 4 institutions in 2 countries.

Sergio Villanueva-SazClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain. svs@unizar.es.
Mariví MartínezClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Jacobo GinerClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Ana GonzálezClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Ana Pilar TobajasInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
María Dolores PérezInstituto Agroalimentario de Aragón-IA2 (Universidad de Zaragoza-CITA), Zaragoza, Spain.
Erandi Lira-NavarreteInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Edificio I+D, Campus Rio Ebro, Zaragoza, Spain.
Andrés Manuel González-RamírezInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Edificio I+D, Campus Rio Ebro, Zaragoza, Spain.
Javier Macías-LeónInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Edificio I+D, Campus Rio Ebro, Zaragoza, Spain.
Maite VerdeClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Andrés YzuelClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Ramón Hurtado-GuerreroInstitute for Biocomputation and Physics of Complex Systems (BIFI), University of Zaragoza, Edificio I+D, Campus Rio Ebro, Zaragoza, Spain.
Maykel AriasAragon Health Research Institute (IIS Aragón), Zaragoza, Spain.
Llipsy SantiagoAragon Health Research Institute (IIS Aragón), Zaragoza, Spain.
Jordi Aguiló-GisbertServicio de Análisis, Investigación, Gestión de Animales Silvestres (SAIGAS), Facultad de Veterinaria, Universidad Cardenal Herrera-CEU, Valencia, Spain.
Héctor RuízDeparment of Animal Pathology, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Delia LacastaDeparment of Animal Pathology, Veterinary Faculty, University of Zaragoza, Zaragoza, Spain.
Diana MartelesClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain.
Antonio FernándezClinical Immunology Laboratory, Veterinary Faculty, University of Zaragoza, 50013, Zaragoza, Spain. afmedica@unizar.es.
Universidad de Zaragoza · ESCentro de Investigación y Tecnología Agroalimentaria de Aragón · ESInstituto de Investigación Sanitaria Aragón · ESUniversidad Cardenal Herrera CEU · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe Acute Respiratory Syndrome Coronavirus 2 is the causative agent of Coronavirus Disease 2019 in humans. Among domestic animals, cats are more susceptible to SARS-CoV-2 than dogs. The detection of anti-SARS-CoV-2 antibodies in seemingly healthy cats and/or infected cats which are in close contact with infected humans has been described. The presence of animals that tested positive by serology or molecular techniques could represent a potential transmission pathway of SARS-CoV-2 that can spill over into urban wildlife. This study analyses the seroprevalence variation of SARS-CoV-2 in stray cats from different waves of outbreaks in a geographical area where previous seroepidemiological information of SARS-CoV-2 was available and investigate if SARS-CoV-2-seropositive cats were exposed to other co-infections causing an immunosuppressive status and/or a chronic disease that could lead to a SARS-CoV-2 susceptibility. For this purpose, a total of 254 stray cats from Zaragoza (Spain) were included. This analysis was carried out by the enzyme-linked immunosorbent assay using the receptor binding domain of Spike antigen and confirmed by serum virus neutralization assay. The presence of co-infections including Toxoplasma gondii, Leishmania infantum, Dirofilaria immitis, feline calicivirus, feline herpesvirus type 1, feline leukemia virus and feline immunodeficiency virus, was evaluated using different serological methods. A seropositivity of 1.57% was observed for SARS-CoV-2 including the presence of neutralizing antibodies in three cats. None of the seropositive to SARS-CoV-2 cats were positive to feline coronavirus, however, four SARS-CoV-2-seropositive cats were also seropositive to other pathogens such as L. infantum, D. immitis and FIV (n = 1), L. infantum and D. immitis (n = 1) and L. infantum alone (n = 1).Considering other pathogens, a seroprevalence of 16.54% was detected for L. infantum, 30.31% for D. immitis, 13.78%, for T. gondii, 83.86% for feline calicivirus, 42.52% for feline herpesvirus type 1, 3.15% for FeLV and 7.87% for FIV.Our findings suggest that the epidemiological role of stray cats in SARS-CoV-2 transmission is scarce, and there is no increase in seropositivity during the different waves of COVID-19 outbreaks in this group of animals. Further epidemiological surveillances are necessary to determine the risk that other animals might possess even though stray cats do not seem to play a role in transmission.

Indexed as

Cat DiseasesCoinfectionCOVID-19Dirofilaria immitisDog DiseasesImmunodeficiency Virus, FelineAnimalsCatsCross-Sectional StudiesDisease OutbreaksDogsHumansLeukemia Virus, FelineSARS-CoV-2Seroepidemiologic StudiesSpainCOVID-19, stray catsELISASARS-CoV-2SerologyVNT

Identifiers

PMID36229725
PMCPMC9560875
OpenAlexW4306152291

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.